Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asfotase alfa in infantile hypophosphatasia
NCT00744042Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- May 2010
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Started Sep 2008; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT00744042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744042.